End-of-day quote
Shenzhen S.E.
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
9.47
CNY
|
-0.63%
|
|
+7.37%
|
-15.97%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,802
|
2,367
|
4,141
|
2,580
|
2,318
|
1,948
|
-
|
-
|
Enterprise Value (EV)
1 |
1,802
|
2,367
|
4,141
|
2,580
|
2,318
|
1,948
|
1,948
|
1,948
|
P/E ratio
|
-
|
17.9
x
|
27.6
x
|
22.4
x
|
38.9
x
|
28.7
x
|
14.7
x
|
22
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.24
x
|
2.63
x
|
3.47
x
|
2.39
x
|
2.49
x
|
2.07
x
|
1.37
x
|
1.78
x
|
EV / Revenue
|
2.24
x
|
2.63
x
|
3.47
x
|
2.39
x
|
2.49
x
|
2.07
x
|
1.37
x
|
1.78
x
|
EV / EBITDA
|
-
|
12.7
x
|
19.4
x
|
15.3
x
|
22.4
x
|
16.8
x
|
9.41
x
|
12.1
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
2.57
x
|
4.09
x
|
2.41
x
|
2.18
x
|
1.78
x
|
1.6
x
|
1.67
x
|
Nbr of stocks (in thousands)
|
203,813
|
203,800
|
205,735
|
205,735
|
205,716
|
205,716
|
-
|
-
|
Reference price
2 |
8.843
|
11.61
|
20.13
|
12.54
|
11.27
|
9.470
|
9.470
|
9.470
|
Announcement Date
|
2/27/20
|
2/25/21
|
2/24/22
|
2/20/23
|
2/23/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
804.9
|
900.3
|
1,193
|
1,078
|
929.8
|
939.1
|
1,426
|
1,094
|
EBITDA
1 |
-
|
186.9
|
213.1
|
168.3
|
103.5
|
116
|
206.9
|
160.7
|
EBIT
1 |
-
|
155.1
|
175.3
|
134.8
|
62.01
|
83.05
|
155.4
|
107.8
|
Operating Margin
|
-
|
17.23%
|
14.7%
|
12.5%
|
6.67%
|
8.84%
|
10.89%
|
9.85%
|
Earnings before Tax (EBT)
1 |
-
|
149.6
|
167.8
|
128
|
61.63
|
77.72
|
149.2
|
102.4
|
Net income
1 |
96.85
|
137.3
|
154.8
|
119.3
|
60.51
|
70.34
|
137.2
|
92.08
|
Net margin
|
12.03%
|
15.25%
|
12.98%
|
11.06%
|
6.51%
|
7.49%
|
9.62%
|
8.42%
|
EPS
2 |
-
|
0.6500
|
0.7300
|
0.5600
|
0.2900
|
0.3300
|
0.6450
|
0.4300
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/27/20
|
2/25/21
|
2/24/22
|
2/20/23
|
2/23/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
15.2%
|
15.5%
|
11.1%
|
5.51%
|
6.09%
|
10.5%
|
7.52%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
10.5%
|
11.9%
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
669.9
|
1,153
|
-
|
Book Value Per Share
2 |
-
|
4.520
|
4.920
|
5.190
|
5.180
|
5.330
|
5.920
|
5.660
|
Cash Flow per Share
2 |
-
|
0.5300
|
0.8000
|
0.6000
|
0.3800
|
1.340
|
-0.2300
|
1.480
|
Capex
1 |
-
|
49.7
|
62
|
18.4
|
61.9
|
96.5
|
92.8
|
91.5
|
Capex / Sales
|
-
|
5.52%
|
5.2%
|
1.71%
|
6.65%
|
10.28%
|
6.5%
|
8.36%
|
Announcement Date
|
2/27/20
|
2/25/21
|
2/24/22
|
2/20/23
|
2/23/24
|
-
|
-
|
-
|
Last Close Price
9.47
CNY Average target price
11.78
CNY Spread / Average Target +24.45% Consensus |
1st Jan change
|
Capi.
|
---|
| -15.97% | 269M | | +13.34% | 64.32B | | -3.95% | 45.95B | | +13.12% | 39.61B | | +20.84% | 25.74B | | +8.52% | 18.75B | | -0.62% | 17.23B | | -21.03% | 15.86B | | +0.91% | 15.03B | | -15.13% | 13.99B |
Other Specialty Chemicals
|